Treatment of multiple sclerosis (MS) with Campath-1H

Details for Australian Patent Application No. 2007296857 (hide)

Owner Genzyme Corporation Bayer Schering Pharma Aktiengesellschaft

Inventors Sachse, Andreas; Margolin, David Harris

Agent Davies Collison Cave

Pub. Number AU-A-2007296857

PCT Pub. Number WO2008/031626

Priority 06090169.1 14.09.06 EP; 60/844/251 13.09.06 US

Filing date 11 September 2007

Wipo publication date 20 March 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

19 March 2009 PCT application entered the National Phase

  PCT publication WO2008/031626 Priority application(s): WO2008/031626

1 October 2009 Assignment before Grant

  Bayer Schering Pharma Aktiengesellschaft; Genzyme Corporation The application has been assigned to Genzyme Corporation; Alcafleu Management GmbH & Co. KG

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007296859-Packaging for substance comprising a container and a hinged two-part lid

2007296854-Pharmaceutical formulations comprising clopidogrel